Untargeted metabolomics profiling and hemoglobin normalization for archived newborn dried blood spots from a refrigerated biorepositoryShow others and affiliations
2020 (English)In: Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, E-ISSN 1873-264X, Vol. 191, article id 113574Article in journal (Refereed) Published
Abstract [en]
Archived dried blood spots (DBS) following newborn screening are an attractive resource for interrogating early-life biology using untargeted metabolomics. Therefore, they have the potential to substantially aid etiological studies, particularly for rare and low-frequency childhood diseases and disorders. However, metabolite quantification in DBS is hindered by variation sources not present in serum and plasma samples such as the hematocrit effect and unknown initial blood volumes. Hemoglobin (Hb) is an appropriate correlate for hematocrit in experimentally-generated DBS punches. However, since many biorepositories worldwide archive DBS at 4-5 °C, there is a need to validate the utility of Hb for DBS archived under refrigeration. We evaluated two simple spectroscopic methods for measuring Hb in DBS stored at 4 +/- 2 °C for up to 21 years, obtained from the newborn screening program at the Karolinska University Hospital, Sweden. Spearman correlation analysis and Akaike Information Criterion model selection found that measurement of a Hb sodium lauryl sulfate complex at 540 nm better described nuisance variation than Hb measured at 404 nm, or using age of spot alone. This is the first study to profile metabolites and to propose a normalization factor for metabolite measurements from DBS archived for decades at 4 °C.
Place, publisher, year, edition, pages
Elsevier, 2020. Vol. 191, article id 113574
Keywords [en]
Dried blood spot, Hemoglobin, LC–MS, Metabolomics, Newborn screening, Sample storage
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-85739DOI: 10.1016/j.jpba.2020.113574ISI: 000579528000017PubMedID: 32896810Scopus ID: 2-s2.0-85090189036OAI: oai:DiVA.org:oru-85739DiVA, id: diva2:1469811
Funder
Swedish Foundation for Strategic Research , RB13-0160
Note
Funding Agencies:
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Environmental Health Sciences (NIEHS) U2CES026561 U2CES030859 P30ES23515
Örebro University Hospital Research Foundation OLL-790011
2020-09-222020-09-222025-08-25Bibliographically approved